Celldex Therapeutics Inc (CLDX)
R&D Expense Growth
-7.47%
Quarterly · Period ending:
CLDX R&D Expense Growth
Latest reported-7.47%period ending
Latest reported-7.47%period ending
CLDX Quarterly R&D Growth (QoQ) (0.00% → -7.47%)
Latest values, visible window
High-resolution chart · PNG
CLDX r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 36.8094% | |
| 7.4348% | |
| 12.4153% | |
| 67.7638% | |
| 8.0009% | |
| -16.3229% | |
| 14.3053% | |
| 0% | |
| 0% | |
| 18.75% | |
| -11.1111% | |
| 50% | |
| 9.0909% | |
| -8.3333% | |
| -7.6923% | |
| -13.3333% | |
| 15.3846% | |
| -18.75% | |
| 6.6667% | |
| 7.1429% | |
| -6.6667% | |
| -25% | |
| 0% | |
| 0% | |
| 0% | |
| 42.8571% | |
| -36.3636% | |
| -12% | |
| -3.8462% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |